Protesters gathered outside Barrie City Hall to demand that the Ontario Provincial government fund a proposed supervised consumption site in Barrie.

The Simcoe County branch of the Canadian Mental Health Association (CMHA) withdrew the application after waiting over two years for provincial approval.

The previous city council endorsed the proposal in 2021. The federal government approved the application in 2022 by granting an exemption to a section of the Controlled Drugs and Substances Act (CDSA). The federal approval was further renewed in 2023.

Community leaders, including former Barrie councillor and harm reduction worker Keenan Aylwin and Christine Nayler, co-founder of Ryan’s Hope, spoke, demanding immediate funding from the province.

Keenan Aylwin, a former Barrie city councillor and harm reduction worker at the Gilbert Centre, highlighted the ongoing impact of colonialism and the racist nature of the war on drugs. He emphasized the severe drug crisis in Barrie, where many are losing loved ones due to government inaction. 

Aylwin stressed that people who use drugs deserve dignity, safety, and care, criticizing politicians for defunding harm reduction programs and vital social services. He called for immediate support for services like supervised consumption sites and safe supply to address the crisis.

He argues that harm reduction recognizes the dignity of all people, deserving of love and support. He criticizes politicians like Premier Ford and Conservative leader Pierre Poilievre, as well as centrist liberals in Ottawa, for using the issue to gain power, thereby sacrificing lives. 

Aylwin points out that criminalizing drugs increases the risk of overdoses, infections, and deaths while diverting funds from vital social services to policing. He calls for immediate harm reduction measures such as safe supply, supervised consumption sites, and housing for all to prevent further preventable deaths.

Christine Nayler, Co-founder of Ryan's Hope, last week encapsulated the frustration and sorrow experienced by those working tirelessly to combat the drug crisis in Ontario. "Six years of our community working so hard to bring a level of SCS to reality and in an instant all that work was just gone," she said, attributing the setback to "political cowardice, ignorance, and arrogance."

Nayler's emotional response, a mix of anger and despair, highlights the profound disappointment felt by advocates when political inaction stifles critical initiatives. "I wanted to scream from the rooftops, but instead I retreated to my bedroom to cry," she confesses. The helplessness turned into a private outburst of anger directed at Doug Ford and his administration, whom she blames for the stagnation of their efforts: "I cursed Doug Ford and his narrow-minded minions."

The impact of this political negligence is stark, with Nayler citing troubling statistics: "In May 2024, there were 16 suspected drug-related deaths in Simcoe County. In 2023, 53 people lost their lives to suspected drug poisonings. So far in 2024, 26 people have lost their lives to suspected drug-related deaths in our community."

Criticizing the Ontario government's disregard for expert advice and evidence, Nayler emphasizes the public health emergency at hand. The government's approach not only fails to address the crisis but also devalues the lives of those affected, treating them as "less valuable and disposable."

The issue, however, is not confined to Ontario. Nayler highlights a nationwide trend where conservative politics undermine effective drug policies. From BC's re-criminalization of simple drug possession to the crackdown on public drug use in cities, vulnerable populations face heightened risks. These regressive measures lead to increased overdose deaths due to isolation.

Nayler also criticizes the Federal Liberal government for ignoring its task force recommendations, failing to implement measures that would reduce gun deaths and save lives. The pervasive influence of politics, she argues, is stalling progress and costing lives, pushing Canada backward in drug policy.